Hepatocyte growth factor/scatter factor disrupts epithelial tumour cell-cell adhesion: Involvement of β-catenin

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 509-517

  Hiscox, S ^a   Jiang, W G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

catenin; C met; Cell adhesion; E cadherin; Hepatocyte growth factor scatter factor; Phosphorylation

Indexed keywords

BETA CATENIN; CELL PROTEIN; CELL SURFACE PROTEIN; CRYSTAL VIOLET; SCATTER FACTOR; UVOMORULIN;

ARTICLE; CELL ADHESION; CELL STRUCTURE; COLORECTAL TUMOR; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR CELL; TUMOR CELL LINE; WESTERN BLOTTING;

BETA CATENIN; CADHERINS; CELL ADHESION; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; HEPATOCYTE GROWTH FACTOR; HUMANS; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0032897382     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hart IR, Goode NT, and Wilson RE: Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989: 65-84, 1989.
2. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
3. Birchmeier W: E-cadherin as a tumour (invasion) suppressor gene. Bioessays 17: 97-99, 1995.
4. Gumbiner M: Cell adhesion, The molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996.
5. Marcel MM, Berx G, Van Roy F, and Brake M. Cadherin/catenin complex, a target for antiinvasive therapy?. J Cell Biochem 61: 524-530, 1996.
6. Jiang WG: E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surg 83: 437-446, 1996.
7. Chen WC, and Obrink B: Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells. J Cell Biol 114: 319-327, 1991.
8. Nagafuchi A, Shirayoshi Y, Yasuda K, and Takeichi M: Transformation of cell-adhesion property by exogenously introduced E-cadherin cDNA. Cell Structure Function 12: 628-633, 1987.
9. Bongiorno PF, Al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, Orringer MB, and Beer DG: E-cadherin expression in primary and metastatic thoracic neoplasms and in Barretts oesophagus. Br J Cancer 71: 166-172, 1995.
10. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, and Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53: 3241-3245, 1993.
11. Berx G, Cleton-Jansen AM, Nollet F, De Leeuw WJ, Van de Vijver M, Cornelisse C, and Van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14: 6107-6115, 1995.
12. Kemler R: Classical cadherins. Sem Cell Biol 3: 149-155, 1992.
13. Hinck L, Nathke IS, Papkoff J, and Nelson WJ: Dynamics of cadherin/catenin complex formation, novel protein interactions and pathways of complex assembly. J Cell Biol 125: 1327-1340, 1994.
14. Ozawa M, Baribault H, and Kemler R: The cyoplasmic domain of the cell adhesion molecule, uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8: 1711-1717, 1990.
15. Watanabe M, Nagafuchi A, Tsukita S, and Takeichi M: Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127: 247-256, 1994.
16. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, and Takeichi M: Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell 70: 293-301, 1992.
17. Birchmeier W, Hulsken J, and Behrens J: Adherens junction proteins in tumour progression. Cancer Surveys 24: 129-140, 1995.
18. Raftopoulos JS, and Kouraklis G: Dysfunction of the E-cadherin/catenin cell adhesion cascade in epithelial cancers. Oncol Rep 3: 793-803, 1996.
19. Nakamura T, Nawa K, and Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats Biochem Biophys Res Commun 122: 1450-1459, 1984.
20. Stoker M, and Ferryman M: An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 77: 209-223, 1985.
21. Jiang WG, Lloyds D, Puntis MCA, Nakamura T, and Hallett MB: Regulation of spreading and growth of human colon cancer cells by hepatocyte growth factor. Clin Exp Met 11: 235-242, 1993.
22. Sunitha I, Meighen DL, Hartman DP, Thompson EW, Byers SW, and Avigan MI: Hepatocyte growth-factor stimulates invasion across reconstituted basement-membranes by a new human small-intestinal cell-line. Clin Exp Metastasis 12: 143-154, 1994.
23. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, and Rosen EM: Scatter factor induces blood-vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941, 1993.
24. Di Renzo MF, Poulsom R, and Olivero M: Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55: 1129-1138, 1995.
25. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilolti S, Belfiore A, Costantino A, Vigneri R, Pierotti MA,and Comoglio PM: Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7: 2549-2553, 1992.
26. Doki Y, Shiozaki H, Tahara H, Inoue M, Oda H, Iihara K, Kadowaki T, Takeichi M, and Mori T: Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line Cancer Res 53: 3421-3426, 1993.
27. Maguire TM, Shering SG, Mcdermott EW, Fennelly JJ, Crown J, and Duffy MJ: Assay of E-cadherin by ELISA in human breast cancers Eur J Cancer 33: 404-408, 1997.
28. Syrigos KN, Krausz T, Waxman J, Pandha H, Rowlinson-Busza G, Verne J, Epenetos AA, and Pignatelli M: E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues, correlation with histopathological grade, tumour stage and survival. Int J Cancer 64: 367-370, 1995.
29. Katagiri A, Watanabe R, and Tomita Y: E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Br J Cancer 71: 376-379, 1995.
30. Nagafuchi A, Ishihara S, and Tsukita S: The role of catenins in the cadherin-medialed cell adhesion, functional analysis of E-cadherin-alpha-catenin fusion molecules. J Cell Biol 127: 235-245, 1994.
31. Ochiai A, Akimoto S, Shimoyama Y, Nagafuchi A, Tsukita S, and Hirohashi S: Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth. Jap J Cancer Res 85: 266-273, 1994.
32. Takeichi M: Cadherins in cancer, implications for invasion and metastasis. Curr Opinion Cell Biol 5: 806-811, 1993.
33. Shibamoto, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M, and Ito F: Tyrosine phosphorlation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1: 296-305, 1994.
34. Vermeulen S, Van Marck V, Van Hoorde L, Van Roy F, Brake M, and Marcel M: Regulation of the invasion suppressor function of the cadherin/catenin complex. Path Res Pract 192: 694-707, 1996.
35. Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Marcel MM and Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120: 757-766, 1993.
36. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita Sh, and Takeichi M: Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118: 703-714, 1992.
37. Takeda H, Nagafuchi A, Yonemura S, Tsukita S, Behrens J, Birchmeier W, and Tsukita S: V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and ß-catenin is not required for the shift. J Cell Biol 131: 1839-1847, 1995.
38. Volberg T, Zick Y, Dror R, Sahanay I, Gilon C, Levitzki A,and Geiger B: The effects of tyrosine-specific protein phosphorylation on the assembly of adherens junctions. EMBO J 11: 1733-1742, 1992.
39. Sommers CL, Gelmann EP, Kelmer R, Cowin P, and Byers SW: Alterations in ß-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 54: 3544-3552, 1994.
40. Kinch MS, Clark GJ, Der Channing J, and Burridge K: Tyrosine phosphorylation regulated the adhesions of ras-transformed breast epithelia. J Cell Biol 130: 461-471, 1995.
41. Hoschuetzky H, Aberle H, and Kemler R: ß-catenin mediates the interaction of the cadherin catenin complex with epidermal growth factor receptor. J Cell Biol 127: 1375-1380, 1994.
42. Shiozaki H, Kadovaki T, Doki Y, Inoue M, Tamura S, Oka H, Iwazawa T, Matsui S, Shimaya K, Takeichi M, and Mori T: Effect of epidermal growth factor on cadherin-mediated adhesion in a human esophageal cancer cell line. Br J Cancer 71: 250-258, 1945.
43. Tsukita Sh, Tsukita Sa, Nagafuchi A, and Yonemura S: Molecular linkage between cahderins and actin filaments in cell-to-cell adherens juncitons. Curr Opin Cell Biol 4: 834-839, 1992.
44. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura A, Tsukita Sa and Tsukita Sh: Perturbation of cell adhesion and microvilli formation by antisense oligonucleotieds to ERM family members. J Cell Biol 125: 1371-1384, 1994.
45. Jiang WG, Hiscox S, Singharo SK, Puntis MCA, Nakamura T, Mansel RE, and Hallett MB: Induction of tyrosine phsophorylation and translocation of ezrin by hepatocyte growth factor scatter factor. Biochem Biophys Res Commun 217: 1062-1069, 1995.
46. Takayama T, Shiozaki H, Doki Y, Oka H, Inoue M, Yamamoto M, Tamura S, Shibamoto S, Ito F, and Monden M: Aberrant expression and phosphorylation of ß-catenin in human colorectal cancer. Br J Cancer 77: 605-613, 1998.
47. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y, and Tominaga T: Serum concentrations of hepatocyte growth-factor in breast cancer patients. Clin Cancer Res 1: 1031-1034, 1995.
48. Hiscox SE, Hallett MB, Puntis MCA, Nakamura T, and Jiang WG: Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers. Cancer Invest 15: 513-521, 1997.